register

News - MedTech & Diagnostics

Urologist welcomes da Vinci Xi surgical system

Health Industry Hub | March 8, 2021 |

MedTech News: Knox Private Hospital in Victoria is now offering surgeons and patients access to Intuitive’s da Vinci Xi Surgical System and Trumpf operating table.

The advancements in this technology are focused on best outcomes for patients allowing for more complex procedures to be performed.

A/Professor Damien Bolton, a highly revered and skilled Urologist performed the first case using the Da Vinci Xi robot at Knox Private Hospital, a Healthscope private hospital.

The surgical system has integrated table motion which means the ‘robot speaks to the operating table’ during surgery and the patient can be dynamically positioned and repositioned while the surgeon operates. The ability to reposition the operating table allows for the best exposure and access to the anatomy targeted.

A/Professor Bolton said “I did my first, 100th and my 1000th robot case at Knox, but the first operation with this new model Da Vinci Xi robot is the most memorable.

“As good as the best surgical robot you could find anywhere in the world. The optics of the new generation Endoscope plus system offers a level of precision in surgery that was unimaginable only years ago.

“The additional technical features of this surgical robot offer potential for minimally invasive surgery in areas beyond prostate and kidney cancer, including bowel and gynaecological cancers,” he added.

In a recently published study comparing the accuracy of the da Vinci Xi and da Vinci Si for image guidance and automation, the authors concluded “The Xi can achieve sub-millimetric average error. Calibration improves accuracy, but excellent baseline accuracy of the Xi means that calibration may not be needed for some applications. Importantly, the external tracking systems needed to account for setup joint error in the Si are no longer required with the Xi.”


News - Pharmaceuticals

Inside the tensions shaping PBAC decision

Inside the tensions shaping PBAC decision

Health Industry Hub | September 17, 2026 |

The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]

More


News - MedTech & Diagnostics

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

Health Industry Hub | September 17, 2026 |

GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]

More


News - MedTech & Diagnostics

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

Health Industry Hub | September 17, 2026 |

The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]

More


News - Pharmaceuticals

New breast cancer drug fills gap left by Zoladex market withdrawal

New breast cancer drug fills gap left by Zoladex market withdrawal

Health Industry Hub | September 17, 2026 |

From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]

More


This content is copyright protected. Please subscribe to gain access.